Monoferric

Active Ingredient(s): Ferric Derisomaltose
FDA Approved: * January 16, 2020
Pharm Company: * PHARMACOSMOS AS
Category: Anemia

Ferric derisomaltose, sold under the brand name Monoferric, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).[1] It was approved for use in the United States in January 2020.[1][2][3] It is given intravenously.[1] References .mw-par... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Monoferric 100 mg/ml Intravenous Solution

NDC: 49442-9301

Labeler:

Pharmacosmos A/S

Monoferric 500 mg/5ml Intravenous Solution

NDC: 49442-9305

Labeler:

Pharmacosmos A/S

Monoferric 1000 mg/10ml Intravenous Solution

NDC: 49442-9310

Labeler:

Pharmacosmos A/S

Monoferric 100 mg/ml Intravenous Injection, Solution

NDC: 73594-9301

Labeler:

Pharmacosmos Therapeutics Inc.

Monoferric 500 mg/5ml Intravenous Injection, Solution

NDC: 73594-9305

Labeler:

Pharmacosmos Therapeutics Inc.

Monoferric 1000 mg/10ml Intravenous Injection, Solution

NDC: 73594-9310

Labeler:

Pharmacosmos Therapeutics Inc.